Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 23 Burkitt Lymphoma 14 Sarcoma 13 Neoplasms 11 Lymphoma, Follicular 11 Lymphoma 10 Hodgkin Disease 9 Breast Neoplasms 9 Triple Negative Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Non-Hodgkin 8 Endometrial Neoplasms 8 Ovarian Neoplasms 7 Lymphoma, B-Cell 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Wilms Tumor 4 Recurrence 4 Osteosarcoma 4 Neoplasm Metastasis 4 Liposarcoma 4 Fallopian Tube Neoplasms 4 Sarcoma, Ewing 3 Neuroblastoma 3 Lymphoproliferative Disorders 3 Lymphoma, T-Cell 3 Lymphoma, Mantle-Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Leiomyosarcoma 3

Interventions

cemiplimab 1 Transdermal Patch 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cutaneous Squamous Cell Carcinoma × Doxorubicin × 90 days × Clear all

NCT05377905 2026-04-09

cSCC

University of Pittsburgh

Phase 1/2 Recruiting

Cutaneous Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡